Protagonist Therapeutics
PTGX
#2852
Rank
โ‚น508.59 B
Marketcap
โ‚น8,135
Share price
0.67%
Change (1 day)
137.26%
Change (1 year)

Revenue for Protagonist Therapeutics (PTGX)

Revenue in 2025 (TTM): โ‚น17.95 Billion

According to Protagonist Therapeutics 's latest financial reports the company's current revenue (TTM ) is โ‚น18.85 Billion. In 2024 the company made a revenue of โ‚น37.26 Billion an increase over the revenue in the year 2023 that were of โ‚น4.99 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Protagonist Therapeutics from 2015 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚น17.95 B-51.83%
2024 โ‚น37.26 B646.13%
2023 โ‚น4.99 B127.09%
2022 โ‚น2.19 B8.02%
2021 โ‚น2.03 B-2.74%
2020 โ‚น2.09 B12609.89%
2019 โ‚น16.47 M-99.24%
2018 โ‚น2.16 B68.8%
2017 โ‚น1.28 B
2016 N/A
2015 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA